Local Organizing Committee
Omar Aimer
Local Organising Committee Chair, PharmD, PhD, NASoP President
Pharmacist deeply engaged in Pharmacovigilance. Based in Montreal (Canada), Omar is an Executive Committee member and Treasurer of the International Society of Pharmacovigilance (ISoP), President of the North American Chapter and Leader of the Medical Device Safety – Special Interest Group (SIG).
He previously held leadership roles in pharmaceutical companies in Europe and Canada. He holds a Degree in Pharmacy and PhD in Pharmacology from Algiers University, Algeria and a Master in Pharmacovigilance and Drug Safety from Paris Descartes University, France.
Omar has presented in multiple scientific forums with interest in new technologies, medical device safety and the improvement of pharmacovigilance around the world.
Priyanka Yalamanchili
Secretary, PharmD, R.Ph
Priyanka is currently a Manager of Pharmacoepidemiology at Daiichi Sankyo, Inc. in New Jersey, USA. She received her Doctor of Pharmacy (PharmD) degree from Rutgers University in 2021. Priyanka earned her Certificate in Pharmacoepidemiology from Rutgers University in 2023 and plans to graduate with a Master of Science in Epidemiology with a concentration in Pharmacoepidemiology degree in 2024.
Following pharmacy school, she completed a post-doctoral fellowship with Rutgers Institute for Pharmaceutical Industry Fellowships and Daiichi Sankyo, Inc. where she also served as adjunct faculty with the Ernest Mario School of Pharmacy at Rutgers University. Priyanka has been involved with ISoP since 2021 and has enjoyed leading the development of publications on pharmacovigilance.
Genaro Castillon
Delegates Coordinator, MD, MSc
Genaro is currently a Medical Advisor at YOLARX Consultants, based in Montreal, Canada. With a background in general practice, particularly in emergency medicine, Genaro has developed a nuanced understanding of patient care over his ten years in clinical settings. This experience has been invaluable in his transition to pharmaceutical research and drug safety.
Holding a Master of Science in Pharmaceutical Sciences from the Université de Montréal, Genaro’s academic pursuits underscores his dedication to expanding his knowledge in the field. At YOLARX Consultants, his responsibilities include reviewing case safety reports, analyzing medical literature, conducting data analysis, and preparing comprehensive reports, contributing significantly to the understanding of disease treatments and drug safety.
Beyond his responsibilities at YOLARX Consultants, Genaro has been a member of ISoP since 2018, engaging with peers and staying informed about the latest developments in this field.
Hady Hatem
Delegates Coordinator
Hady a pharmacist specialized in pharmacovigilance, brings over 15 years of invaluable experience to the pharmaceutical industry, having worked across the Middle East and Canada. With a medical teaching diploma and certifications in clinical research, drug safety, and pharmacovigilance, he currently serves as a Patient Safety Manager with a sharp focus on risk management.
For the past ten years, Hady has been a university lecturer, playing a pivotal role in shaping the next generation of professionals in the field of pharmacy and pharmacovigilance. His extensive experience includes roles spanning multiple regions.
In 2022, he joined the International Society of Pharmacovigilance (ISoP), further emphasizing his commitment to advancing pharmaceutical safety and standards globally.
Abimbola Cole
Speakers Coordinator, PharmD, MPH
Abimbola is currently a Scientific Director within the Safety Evaluation and Risk Management group at GSK. She received her Doctor of Pharmacy, Master of Public Health and Certificate in Regulatory Affairs and Health Policy from MCPHS University. She subsequently completed a post-doctoral fellowship in Global Pharmacovigilance at Takeda in conjunction with MCPHS University where she also served as adjunct faculty. She has worked in the pharmacovigilance space for 7 years and previously worked in the clinical healthcare setting at Brigham and Women’s Hospital and Walgreen’s Pharmacy as a student pharmacist.
She is also an adjunct faculty at MCPHS University and lectures a fundamentals of Pharmacovigilance course for graduate students. Additionally, she has served as a speaker for the Industry Pharmacists Organization (IPhO) and an advisor at the Biomedical Science Careers Student Conference which is affiliated with Harvard Medical School.
Abimbola joined ISoP in 2018 and has been an active member of NASoP via various working groups and currently serves as the Secretary.
Denny Van Liew
Sponsorship Coordinator, MSc, FRSA
Denny is an Associate Partner at Red Nucleus Solutions; and a business leader committed to helping Global Life Science and Health Care Organizations improve performance. Denny has 20 + years of life science experience with a focus on Clinical Development, Regulatory, Pharmacovigilance, and Medical Affairs.
Projects he leads include process redesign, controlled document streamlining, knowledge management portals, change management, systems integration, and GxP training. He is considered a leader in regulatory and pharmacovigilance activities. Denny has led large corporate transformation projects including the merger of two top 20 pharma Safety Organizations.
Denny is committed to giving back and is active in ISoP activities, NaSOP working groups and served on the Boards of various other nonprofit healthcare organizations focused on the digitization of healthcare and personalized medicine in roles including Treasurer, Secretary and Vice President.
Marina A. Malikova
Abstract Management Coordinator, PhD, MSci, MACI, MBA, RAC
Dr. Malikova is an Assistant Professor of Surgery at Boston University, School of Medicine, and an Executive Director of Research at the Department of Surgery at Boston Medical Center. She is a member of ISoP since 2015, and currently serves as the Coordinator of Special Programs at NASoP.
Dr. Malikova has PhD in Biochemistry with strong background in biomedical sciences. She also holds a Master’s Degree in Clinical Investigation and Master’s of Business Administration in Health Sector Management from Boston University.
She has over 18 years of experience in the biomedical product R&D field, with the past 11 years on executive level.
In her current role as Executive Director, Dr. Malikova macro-manages research programs in 13 divisions of the Department of Surgery at Boston Medical Center. She is responsible for clinical trials and basic biomedical research operations and compliance, strategic planning and execution oversight of clinical trials; safety and risk management.
Dr. Malikova is an instructor for several courses offered by the Am2P PV program. She is a recognized expert in PV regulations, risk and quality management. She became the Eu2P/Am2P Executive Board member in 2022. Currently she leads the NASoP Patient Centricity in PV working group.
Maxine Gossell-Williams
Scientific Committee Coordinator, BSc, PhD
Professor of Pharmacology and Pharmacovigilance in the Faculty of Medical Sciences at The University of the West Indies in Jamaica. She has previously served as member of the National Central Drug and Therapeutics Committee of the Ministry of Health. She regularly presents and trains healthcare professionals in the significance of Pharmacovigilance at workshops and conferences for regulatory bodies, professional societies and market authorization holders.
She has served as primary supervisor for over forty graduate research projects and has over twenty years of significant contribution to curriculum development. She currently hold the position of Coordinator for Masters and PhD programs in the Faculty, as well as Deputy Dean of Graduate Studies in the Faculty of Medical Sciences. She is also a member of the administrative oversight of all five campuses, including the Board of Graduate Studies and Research and the University Library Advisory Committee.
She holds a Degree in Biochemistry and Chemistry and a PhD in Pharmacology from The University of the West Indies. She has been a member of ISoP since 2014.
John Price
Budget Coordinator
John is a physician with extensive experience of regulatory affairs, pharmacovigilance and drug development gained during leadership roles in the UK MHRA, Pfizer, J&J, and Alexion. Now an independent consultant, John supports drug safety and risk management activities, building and leading PV systems at large and small biotech companies.
John is involved in efforts to develop the next generation of PV professionals through the Am2P initiative of ISOP’s North American Chapter, the American Society of PV Physicians, and regular teaching engagements in US and UK.
John serves on advisory boards at two providers of safety and regulatory services to the industry.
